Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Nov-Dec;16(11-12):543-52.
doi: 10.2119/molmed.2010.00107. Epub 2010 Aug 27.

D-chiro-inositol glycans in insulin signaling and insulin resistance

Affiliations
Review

D-chiro-inositol glycans in insulin signaling and insulin resistance

Joseph Larner et al. Mol Med. 2010 Nov-Dec.

Abstract

Classical actions of insulin involve increased glucose uptake from the bloodstream and its metabolism in peripheral tissues, the most important and relevant effects for human health. However, nonoxidative and oxidative glucose disposal by activation of glycogen synthase (GS) and mitochondrial pyruvate dehydrogenase (PDH) remain incompletely explained by current models for insulin action. Since the discovery of insulin receptor Tyr kinase activity about 25 years ago, the dominant paradigm for intracellular signaling by insulin invokes protein phosphorylation downstream of the receptor and its primary Tyr phosphorylated substrates-the insulin receptor substrate family of proteins. This scheme accounts for most, but not all, intracellular actions of insulin. Essentially forgotten is the previous literature and continuing work on second messengers generated in cells in response to insulin. Treatment and even prevention of diabetes and metabolic syndrome will benefit from a more complete elucidation of cellular-signaling events activated by insulin, to include the actions of second messengers such as glycan molecules that contain D-chiro-inositol (DCI). The metabolism of DCI is associated with insulin sensitivity and resistance, supporting the concept that second messengers have a role in responses to and resistance to insulin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
INS-2 structure showing Mn2+ as the chelating metal.
Figure 2
Figure 2
Pathways of insulin signaling.
Figure 3
Figure 3
Structure-activity relationship of phosphate analogues on PDP activity. Percent activation of PDP by 100 μmol/L analogue (40).
Figure 4
Figure 4
Myo-inositol, L-chiro-inositol and DCI. Inversion of the C1 hydroxyl C1 produces L-chiro, and inversion of the C3 hydroxyl produces D-chiro.
Figure 5
Figure 5
Conversion of D-glucose-6-phosphate to myo-inositol-1-phosphate by cyclization. Myo-inositol-1-phosphate is then dephosphorylated to myo-inositol, which then is converted by epimerization of the C3 hydroxyl (dashed left arrow) to DCI.

References

    1. Myers MG, White MF. The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains. Diabetes. 1993;42:643–50. - PubMed
    1. Huijing F, Nuttall F, Villar-Palasi C, Larner J. UDPglucose: alpha-I,4-glucan alpha-4-glucosyl-transferase in heart. Regulation of the activity of the transferase in vivo and in vitro in rat. A dissociation in the action of insulin on transport and on transferase conversion. Biochim Biophys Acta. 1969;177:204–12. - PubMed
    1. Eboué-Bonis D, Chambaut AM, Volfin P, Clauser H. [Selective action of N-ethylmaleimide on insulin stimulation of metabolism in the surviving diaphragm] Bull Soc Chim Biol (Paris) 1967;49:415–31. - PubMed
    1. Larner J, et al. Duality in the mechanism of action of insulin. Adv Second Messenger Phospho-protein Res. 1990;24:290–4. - PubMed
    1. Larner J, et al. Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation. Science. 1979;206:1408–10. - PubMed